Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.14
+0.26 (3.37%)
Feb 6, 2026, 11:53 AM EST - Market open
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
$1,118,331
Profits / Employee
$358,976
Market Cap
1.32B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 645 |
| Intellia Therapeutics | 403 |
| Capricor Therapeutics | 160 |
| AnaptysBio | 136 |
| Kodiak Sciences | 123 |
| DBV Technologies | 117 |
| Taysha Gene Therapies | 73 |
| Savara | 59 |
NVAX News
- 7 days ago - Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? - Seeking Alpha
- 17 days ago - Novavax Announces Entering into a License Agreement with Pfizer - PRNewsWire
- 17 days ago - Novavax enters license agreement with Pfizer for vaccine development - Reuters
- 22 days ago - Novavax, Inc. (NVAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 2 months ago - FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks - Investopedia
- 2 months ago - Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men - Market Watch
- 2 months ago - Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals - Barrons